EDGAR Filing Documents for 0001558370-18-006917

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001558370-18-006917

Filing Date

2018-08-09

Accepted

2018-08-09 17:27:28

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	s-3.htm	S-3	651534
2	EX-1.2	ex-1d2.htm	EX-1.2	361557
3	EX-4.4	ex-4d4.htm	EX-4.4	590865
4	EX-4.5	ex-4d5.htm	EX-4.5	646026
5	EX-4.6	ex-4d6.htm	EX-4.6	94659
6	EX-4.7	ex-4d7.htm	EX-4.7	94900
7	EX-5.1	ex-5d1.htm	EX-5.1	48397
8	EX-12.1	ex-12d1.htm	EX-12.1	82108
9	EX-23.1	ex-23d1.htm	EX-23.1	3318
10	GRAPHIC	ex-5d1g001.jpg	GRAPHIC	6838
11	GRAPHIC	ex-5d1g002.jpg	GRAPHIC	2387
	Complete submission text file	0001558370-18-006917.txt		2587332

Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453

Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252

Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)